These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38459758)

  • 1. Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock.
    Schurr JW; Ambrosi L; Fitzgerald J; Bermudez C; Genuardi MV; Brahier M; Elliot T; McGowan K; Zaaqoq A; Laskar S; Pope SM; Givertz MM; Mallidi H; Sylvester KW; Seifert FC; McLarty AJ
    Artif Organs; 2024 Aug; 48(8):921-931. PubMed ID: 38459758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients.
    Lamba HK; Kim M; Santiago A; Hudson S; Civitello AB; Nair AP; Loor G; Shafii AE; Liao KK; Chatterjee S
    J Artif Organs; 2022 Mar; 25(1):16-23. PubMed ID: 33982206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization.
    Mastoris I; Tonna JE; Hu J; Sauer AJ; Haglund NA; Rycus P; Wang Y; Wallisch WJ; Abicht TO; Danter MR; Tedford RJ; Fang JC; Shah Z
    Circ Heart Fail; 2022 Jan; 15(1):e008777. PubMed ID: 34879706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of extracorporeal membrane oxygenation in patients with therapy refractory cardiogenic shock as a bridge to implantable left ventricular assist device and perioperative right heart support.
    Scherer M; Moritz A; Martens S
    J Artif Organs; 2009; 12(3):160-5. PubMed ID: 19894089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization.
    Pagani FD; Lynch W; Swaniker F; Dyke DB; Bartlett R; Koelling T; Moscucci M; Deeb GM; Bolling S; Monaghan H; Aaronson KD
    Circulation; 1999 Nov; 100(19 Suppl):II206-10. PubMed ID: 10567305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device Strategies for Patients in INTERMACS Profiles 1 and 2 Cardiogenic Shock: Double Bridge With Extracorporeal Membrane Oxygenation and Initial Implant of More Durable Devices.
    Cheng R; Ramzy D; Azarbal B; Arabia FA; Esmailian F; Czer LS; Kobashigawa JA; Moriguchi JD
    Artif Organs; 2017 Mar; 41(3):224-232. PubMed ID: 27658844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal Membrane Oxygenation as a Bridge to Durable Mechanical Circulatory Support: An Analysis of the STS-INTERMACS Database.
    Loyaga-Rendon RY; Boeve T; Tallaj J; Lee S; Leacche M; Lotun K; Koehl DA; Cantor RS; Kirklin JK; Acharya D
    Circ Heart Fail; 2020 Mar; 13(3):e006387. PubMed ID: 32164436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single center outcomes after temporary mechanical circulatory assist device prior to Heartmate 3 implantation - a retrospective cohort study.
    Iversen IJ; Gustafsson F; Rossing K; Møller-Sørensen PH; Olsen PS; Møller CH
    Scand Cardiovasc J; 2024 Dec; 58(1):2353066. PubMed ID: 38962929
    [No Abstract]   [Full Text] [Related]  

  • 10. Different Clinical Course and Complications in Interagency Registry for Mechanically Assisted Circulatory Support 1 (INTERMACS) Patients Managed With or Without Extracorporeal Membrane Oxygenation.
    Han JJ; Chung J; Chen CW; Gaffey AC; Sotolongo A; Justice C; Ameer AE; Rame JE; Bermudez C; Acker MA; Atluri P
    ASAIO J; 2018; 64(3):318-322. PubMed ID: 28938306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcome After Venoarterial Extracorporeal Membrane Oxygenation as Bridge to Left Ventricular Assist Device Preceding Heart Transplantation.
    Coeckelenbergh S; Valente F; Mortier J; Engelman E; Roussoulières A; El Oumeiri B; Antoine M; Van Obbergh L; Taccone FS; Vanden Eynden F; Stefanidis C
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1694-1702. PubMed ID: 34330577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non-Left Ventricular Assist Device Centers.
    Wang JI; Lu DY; Mhs ; Feldman DN; McCullough SA; Goyal P; Karas MG; Sobol I; Horn EM; Kim LK; Krishnan U
    J Am Heart Assoc; 2020 Dec; 9(23):e017326. PubMed ID: 33222608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal impact of temporary mechanical circulatory support on durable ventricular assist device outcomes: An IMACS registry propensity matched analysis.
    Hernandez-Montfort JA; Xie R; Ton VK; Meyns B; Nakatani T; Yanase M; Pettit S; Shaw S; Netuka I; Kirklin J; Goldstein DJ; Cowger J
    J Heart Lung Transplant; 2020 Feb; 39(2):145-156. PubMed ID: 31866174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation as a bridge to advanced heart failure therapies.
    Acharya D; Manandhar-Shrestha N; Leacche M; Rajapreyar I; William P; Kazui T; Hooker R; Tonna J; Jovinge S; Loyaga-Rendon R
    J Heart Lung Transplant; 2023 Aug; 42(8):1059-1071. PubMed ID: 36964083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.
    Toda K; Fujita T; Seguchi O; Yanase M; Nakatani T
    J Artif Organs; 2018 Mar; 21(1):39-45. PubMed ID: 28871334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: De-escalate and ambulate.
    Bertoldi LF; Pappalardo F; Lubos E; Grahn H; Rybczinski M; Barten MJ; Legros T; Bertoglio L; Schrage B; Westermann D; Lapenna E; Reichenspurner H; Bernhardt AM
    J Crit Care; 2020 Jun; 57():259-263. PubMed ID: 32061461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with temporary mechanical circulatory support before minimally invasive centrifugal left ventricular assist device.
    Sorensen EN; Griffith BP; Feller ED; Kaczorowski DJ
    J Card Surg; 2020 Jul; 35(7):1539-1547. PubMed ID: 32579786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life and Mid-Term Survival of Patients Bridged with Extracorporeal Membrane Oxygenation to Left Ventricular Assist Device.
    Unai S; Yamane K; Tanaka D; Cook G; Hirose H; Cavarocchi NC; Entwistle JWC
    ASAIO J; 2017; 63(3):273-278. PubMed ID: 27861427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.